In an opinion piece marking the 25th anniversary of the 2001 anthrax letters, Daniel Jernigan, a former CDC investigator who led the epidemiology team during the response, argues that the attack still holds three key lessons for today's biothreat landscape. The letters caused 22 cases of anthrax and five deaths, and the investigation revealed that the clinical picture was far more complex than expected—half the cases were cutaneous, while the rest were inhalational and often fatal.
Jernigan emphasizes that early assumptions based on pre-existing knowledge proved wrong. Prior guidance focused on direct exposure when an envelope was opened, but severe disease among postal workers showed that spores could be re-aerosolized along the mail pathway. This forced a rethink of prophylaxis and decontamination, ultimately leading to antimicrobial treatment for an estimated 32,000 people.
He also notes that while detection technology has improved and mail screening is more robust, biodefense programs have been cut across civilian and military sectors. Citing recent reports, he warns that AI now makes it easier to develop or generate biothreat pathogens, raising risks that are "growing rapidly." The source does not offer a direct comparison to other perspectives, but its single-author viewpoint is consistent throughout, urging that the lessons of 2001—look beyond intended targets, question assumptions, and prepare for the unexpected—remain essential.
Jernigan concludes that the infrastructure to respond to natural and intentional infectious disease outbreaks is vulnerable, and that the public health community must apply the hard-won insights from the anthrax investigation to meet the next challenge, whether human-made or AI-generated.